RxDoctor Payments Data

Pamela Bernard

Optometrist · Loveland, OHNPI 1750384194

Payments from drug & device makers

$6,562in general payments, 2019–2025

Across 75 payments — averaging $87.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
  • Alcon$2K
  • Johnson & Johnson Vision Care, Inc.$1K
  • Optos, Inc.$417
  • Coopervision Inc.$367
  • Bausch & Lomb Americas Inc.$275
  • plus $706 from 7 others

What the payments were for

  • Travel & lodging$3,65556%
  • Food & beverage$2,64940%
  • Gifts$170%
  • Entertainment$2404%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,562 in reported general payments places this provider in the 90th percentile of 1,995 optometrist providers in Ohio.

See all optometrist providers in Ohio

Medicare billing

Part B allowed, 2024
$40,685
Medicare patients
179
Services billed
461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RocklatanNetarsudil Mesylat/Latanoprost21$11,854
XiidraLifitegrast12$10,893
RestasisCyclosporine11$7,415
Timolol Maleate30$1,359
Bimatoprost15$1,204
Latanoprost172$1,175
Brimonidine Tartrate16$561
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat50$358
Dorzolamide Hcl22$248

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Bausch & Lomb Americas Inc.Xiidra$275$10,89312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,995 optometrist providers in Ohio.

Other optometrist in Loveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →